ReviewNeurology and therapy2026

International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges.

Andrew Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.